Latest filing published 12 Apr 2007 for Molecular Insight Pharmaceuticals, Inc., €155k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Lionel N. Sterling: trading record in brief
This profile gathers the share dealings of Lionel N. Sterling in Molecular Insight Pharmaceuticals, Inc. Activity is concentrated on a single trading day, 1 February 2007, with 5 filings.
Purchases make up the whole of the open-market record (1 purchase, €155k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 12 April 2007 with an open-market purchase (€155k) in Molecular Insight Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lionel N. Sterling
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,400 shares@ US$14.00Common StockSEC:0001209191-07-023723:0Canonical exit: 2 May 2007 (T+90)
- 38,009 sharesCommon StockSEC:0001209191-07-007530:0
- 101,199 sharesCommon StockSEC:0001209191-07-007530:1
- 63,940 sharesCommon StockSEC:0001209191-07-007530:2
- 17,680 shares@ US$3.96Common StockSEC:0001209191-07-007530:3
5 of 5 declarations
